Stollery Childrens' Hospital
Edmonton, Alberta, T6G 2B7, Canada
NCT Number: NCT02028832
This study will investigate if adding complementary therapies such as acupuncture, massage and reiki to inpatient pediatric care is feasible and what the effects are on outcomes such as patient symptoms, cost, safety, satisfaction and length of stay.
Looking for future studies?
Notify MeUp to 16 year
All sexes
Interventional
Phase 3
Edmonton, Alberta, T6G 2B7, Canada
Study Objective: To determine if a pediatric integrative medicine (PIM) service is effective in reducing overall symptoms of pain, nausea/vomiting, and/or anxiety (PNVA), length of stay, and costs, in hospitalized children when compared to conventional care. In this context, "integrative" refers to a combined approach of complementary and conventional medical therapies in an evidence-based fashion.
Design: cluster trial; 2-arm controlled evaluation study in pediatric oncology, general pediatrics and pediatric cardiology. Intervention will be offered during a 6-month PIM period following a 6 month control period.
Population: Inclusion criteria: (i) In-patients in participating division and (ii) informed consent/assent. Exclusion criteria: (i) lack of parent participation, fluency in English, or informed consent
Intervention: Recommendations for specific CAM therapies will be determined by a staff PIM pediatrician. Any combination of the following CAM therapies (dose, duration, amount to be based on patient need as assessed by CAM provider, patient, and parent): acupuncture/acupressure, massage, Reiki; all are to be offered in addition to usual care.
Control: Usual care.
Outcomes: Primary outcome: feasibility (i.e enrollment); Secondary outcomes: (i) PNVA symptom management, (ii) need for conventional pharmacotherapy, (iii) adverse events; (iv) parent and health care provider satisfaction with care provided, v) length of stay; and vi) cost-effectiveness (analysis of this outcome to be limited to patients admitted for at least 2 days and for not more than 30 days).
Significance: To our knowledge, this study will be the first comparative effectiveness trial to assess the impact of PIM for hospitalized children with cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
If service is requested, treatment options include acupuncture/acupressure, massage, and reiki
Usual care consists of all conventional care options in pediatric oncology including medication and other therapies.
Time frame: up to 5 days
Enrollment of study participants over length of study which will inform conduct of a larger study in this population
Time frame: up to 5 days
For pre-verbal children: Faces, Legs, Activity, Cry, Consolability tool Verbal children: faces Pain Scale-Revised
Time frame: up to 5 days
Baxter Retching Faces scale
Time frame: up to 5 days
Pediatrics Anxiety Faces scale
Time frame: up to 5 days
BC Children's Hospital Patient Safety Questionnaire; Canadian Pediatric Trigger tool
Time frame: up to 5 days
Hospital's standardized satisfaction survey; State-Trait Anxiety Invenvtory
Time frame: up to 5 days
Time frame: Analysis of this outcome to be limited to patients admitted for at least 2 days and for not more than 30 days
Resource utilization and related costs will be compared between study arms
University of Alberta
Other
Pilot Study of Pediatric Integrative Medicine in Pediatric Oncology, General Pediatrics and Pediatric Cardiology
Acronym: PIM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06040411
Anxiety Disorders, Anxiety State
Yenişehir, Mersin, Turkey (Türkiye)
View Trial DetailsNCT07328477
Agnosia, Anxiety
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06439121
Nausea, Nausea, Postoperative
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT03948074
Anxiety, Anxiety Disorders
Calgary, Alberta, Canada
View Trial Details